C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors Bio N Tech Se Transaction History
C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors
- $1.18 Trillion
- Q4 2024
A detailed history of C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors transactions in Bio N Tech Se stock. As of the latest transaction made, C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors holds 9,810 shares of BNTX stock, worth $1.19 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
9,810Holding current value
$1.19 Million% of portfolio
0.38%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
359Shares Held
38.5MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.01 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$547 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$528 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$230 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$219 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...